pocketful logo
Albert David Ltd logo

Albert David Ltd

NSE: ALBERTDAVD BSE: 524075

₹735.95

(-1.90%)

Wed, 18 Feb 2026, 02:45 am

Albert David Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    421.40

  • Net Profit

    17.20

  • P/B

    1.18

  • Sector P/E

    39.75

  • P/E

    26.92

  • EV/EBITDA

    14.47

  • Debt/Equity (Industry)

    0.22

  • Interest Cover (Industry)

    10.51

  • ROCE (Industry)

    12.01

  • RONW (Industry)

    11.72

  • ROE

    4.44

  • ROCE

    6.36

  • Debt/Equity

    0.02

  • EPS (TTM)

    16.83

  • Dividend Yield

    0.68

  • Book Value

    689.84

  • Interest Cover

    46.87

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are thoroughly covered by earnings (8.7x coverage).
  • Albert David's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Albert David is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Albert David is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Albert David's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • High level of physical assets or inventory.
  • Tarminder's remuneration is higher than average for companies of similar size in India.
  • Albert David is not covered by any analysts.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters62.2462.2462.2462.2462.13
FII0.600.600.841.010.86
DII1.661.661.661.651.64
Public35.5035.5035.2635.1135.37
Government00000

Read More

Technical Analysis

RSI

57.43

MACD

3.00

50 DMA

724.96

200 DMA

803.81

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic917.88812.23749.82706.58644.17600.93495.28
Fibonacci812.23771.88746.94706.58666.23641.29600.93
Camarilla716.45706.77697.08706.58677.72668.03658.35

Pivots Level: Classic

R3

+211.30

917.88

R2

+105.65

812.23

R1

+43.23

749.82

706.58
706.58
Pivot Point
LTP: 734.25

S1

-62.42

644.17

S2

-105.65

600.93

S3

-211.30

495.28

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    720.82

  • 20-EMA

    714.06

  • 30-EMA

    716.76

  • 50-EMA

    728.74

  • 100-EMA

    759.03

  • 200-EMA

    821.32

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
11 Feb 2026board-meetingsQuarterly Results
12 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
13 May 2025agm
13 May 2025dividend₹5.00 Dividend /Share25 Jul 2025
13 May 2024dividend₹11.50 Dividend /Share02 Aug 2024
13 May 2024agm
19 May 2023dividend₹9.00 Dividend /Share03 Aug 2023
19 May 2023agm
05 Jul 2022agm
11 May 2022dividend₹9.00 Dividend /Share02 Aug 2022

Read More

Peer Comparison

Albert David Ltd logo

Albert David Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Albert David Ltd About

Albert David is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1938

Headquarters

CEO

A K Kothari

Employees

Contact

Website icon

Website

http://www.albertdavidindia.com

Email icon

Email

albertdavid@adlindia.in; abchakrabartty@adlindia.i

Phone icon

Phone

91-33-22302330/2262 8436/8456/

Location icon

Location

D Block 3rd Flr Gillander Hous, Netaji Subhas Road, Kolkata, West Bengal, 700001

Read More

Albert David Ltd Company History

YearHistory
2010
  • The company recommended payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each on 5707162 Equity Shares.
2011
  • The company recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended.
2012
  • The company recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended.
2013
  • Albert David Ltd recommended payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each.
2014
  • Albert David Ltd appointed Mr. Arindam Sarkar as Additional Director of the Company.
  • Albert David Ltd recommended dividend of Rs. 5.00 per equity share of Rs. 10/- each.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
GRAVITON RESEARCH CAPITAL LLPBuy290441649.1829 Aug 2024
GRAVITON RESEARCH CAPITAL LLPSell290441652.229 Aug 2024
GRAVITON RESEARCH CAPITAL LLPSell325131553.7226 Aug 2024
GRAVITON RESEARCH CAPITAL LLPBuy325131551.8226 Aug 2024
GRAVITON RESEARCH CAPITAL LLPSell309711403.6523 Aug 2024
GRAVITON RESEARCH CAPITAL LLPBuy309711409.5723 Aug 2024
PARAM CAPITALBuy300001445.623 Aug 2024
GRAVITON RESEARCH CAPITAL LLPBuy447901491.925 Jan 2024
GRAVITON RESEARCH CAPITAL LLPSell447901487.4625 Jan 2024

Read More

Albert David Ltd News

Albert David MD & CEO Umesh Kunte Resigns

Albert David Limited announces resignation of Managing Director and CEO Umesh Manohar Kunte effective December 18, 2025, citing personal reasons and priorities.

18 Dec 2025

stocks

Albert David Limited Reports Quarterly Financial Results for Period Ended September 30, 2025

Albert David Limited announced its unaudited financial results for the quarter and half year ended September 30, 2025. The pharmaceutical manufacturing company reported revenue from operations of Rs. 5,857 lakhs for the quarter, compared to Rs. 7,056.64 lakhs in the previous quarter. The company posted a net loss of Rs. 540.04 lakhs for the quarter versus a loss of Rs. 779.76 lakhs in the prior quarter. For the half year period, revenue from operations stood at Rs. 13,779.18 lakhs with a net loss of Rs. 526.71 lakhs. The company paid a dividend of Rs. 5.00 per equity share during the quarter, resulting in a total outflow of Rs. 285.36 lakhs. The results were reviewed by the Audit Committee and approved by the Board of Directors. The company operates in pharmaceutical manufacturing with one reportable segment.

12 Nov 2025

earnings

Albert David Appoints Dr. Rajiv Anant Desai as Independent Director Through Postal Ballot

Albert David Ltd shareholders approved the appointment of Dr. Rajiv Anant Desai as Independent Director for a five-year term from August 2, 2025 to August 1, 2030 through postal ballot. The special resolution received overwhelming support with 99.99% of votes cast in favor. Dr. Desai holds M.Sc in Chemistry, Ph.D in Pharmaceutical Chemistry, and MBA from NMIMS Mumbai, bringing over 38 years of experience in India and Switzerland. He previously served as Executive Vice President, Global Corporate Quality at Lupin Limited until June 2022 and currently works as Senior Technical Advisor with Indian Pharmaceutical Alliance. The e-voting process ran from August 18 to September 16, 2025, with 135 shareholders participating out of 15,227 total shareholders on record.

17 Sept 2025

corporate governance

Albert David Ltd Seeks Shareholder Approval for Independent Director Appointment via Postal Ballot

Albert David Ltd has issued a postal ballot notice seeking shareholder approval for the appointment of Dr. Rajiv Anant Desai as an Independent Director for a five-year term from August 2, 2025 to August 1, 2030. The e-voting period runs from August 18 to September 16, 2025. Dr. Desai, aged 63, holds M.Sc in Chemistry, Ph.D in Pharmaceutical Chemistry, and MBA qualifications with over 38 years of experience in the pharmaceutical industry. He previously served as Executive Vice President at Lupin Limited and currently works as Senior Technical Advisor with Indian Pharmaceutical Alliance. The company has appointed Mrs. Shikha Gupta as scrutinizer for the postal ballot process. The notice was sent electronically to 13,995 shareholders whose email addresses are registered with the company. Results will be declared within 48 hours of voting conclusion.

13 Aug 2025

corporate action

Albert David Limited Reports Q1 FY2026 Financial Results with Mixed Performance

Albert David Limited published its unaudited financial results for the quarter ended June 30, 2025. The company reported total income from operations of Rs. 7,056.64 lakhs compared to Rs. 8,935.64 lakhs in the corresponding quarter of the previous year. Net profit for the period after tax stood at Rs. 793.76 lakhs versus Rs. 1,884.44 lakhs in Q1 FY2025. The company's equity share capital remained stable at Rs. 570.72 lakhs. Basic and diluted earnings per share were Rs. 13.91 compared to Rs. 33.02 in the same quarter last year. The results were reviewed by the audit committee and approved by the board of directors on August 2, 2025.

04 Aug 2025

earnings

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800